mRNA cancer vaccine
Search documents
Moderna, Merck cancer vaccine shows promise in late-stage trial
CNBC Television· 2026-08-19 15:15
Merc is up by about 5.8%. Madna shares are up by 70% this morning. It's a gain of more than $43 to $107.3%.This comes on positive topline results from a large phase 3 trial of the two companies melanoma treatment. It combines individualized mRNA based therapy with Merc's Kitruda for patients who have had melanoma surgically removed. That trial did meet both its primary and secondary endpoints of survival without recurrence of the cancer as well as survival without the cancer spreading to other parts of the ...
First Look: Meta Faces Trial, Target Surges, Moderna Cancer Vaccine Succeeds
GuruFocus· 2026-08-19 11:58
Legal and Regulatory Risks - Meta Platforms faces a landmark trial brought by California and other states seeking financial penalties and policy changes over alleged social media addiction and youth mental health harms [1][2] - The US Securities and Exchange Commission proposed new rules to clarify digital asset regulation and streamline capital formation for crypto entrepreneurs [5] Market Trends and Macroeconomics - Global government bond yields surged to their highest levels since 2007, raising financing costs and pressuring equity markets worldwide [2][4][5] - Global equity markets experienced volatility and risk-off sentiment, led by heavy selling in AI-related shares, particularly in Asian markets such as South Korea [6][9] - Oil prices climbed due to the expiration of the US-Iran ceasefire and renewed geopolitical risks raising concerns over global supply disruptions [9] Corporate Performance and Industry Dynamics - Unitry Robotics debuted on the Shanghai Star Market, soaring 460% on its first day of trading and closing with a market capitalization near 50 billion USD, becoming China's first listed humanoid robot maker [3] - Target delivered a strong earnings beat for the second quarter of fiscal year 2026 and raised its outlook driven by sales rebounds and a large tariff refund [4] - Moderna and Merck announced that their personalized mRNA cancer vaccine met key endpoints in a late-stage melanoma trial, sending Moderna shares up 50% in pre-market trading [7] - American Airlines announced plans to add 4,000 seatback entertainment screens across more than 800 aircraft and expand premium seating to attract higher-spending travelers [8]